See the DrugPatentWatch profile for Thalidomide
What birth defects did thalidomide cause?
Thalidomide is linked to severe birth defects when taken during pregnancy, especially in the early weeks before many people know they are pregnant. Reported problems include limb abnormalities (such as shortened or missing arms or legs), along with other congenital defects. The syndrome is often described broadly as a pattern of malformations affecting multiple body systems when exposure occurs in utero [1].
When during pregnancy was thalidomide most dangerous?
The risk depends on timing. Thalidomide exposure is most strongly associated with defects during the period when the embryo is rapidly forming organs and body structures. Because major limb development occurs early, taking thalidomide in early pregnancy carries the highest likelihood of causing serious birth defects [1].
How does thalidomide exposure lead to these developmental problems?
The drug’s developmental toxicity relates to how it can interfere with normal embryo development. This includes effects on processes involved in forming blood vessels and tissues, which can disrupt normal growth patterns during the critical stages of fetal development [1].
What conditions led to thalidomide being used (and why it was pulled)?
Thalidomide was used for certain conditions before its pregnancy risks were understood. As evidence of birth defects became clear, its use was restricted and then largely removed from routine prescribing in many places [1].
What regulations and pregnancy-prevention measures exist now?
Because thalidomide can cause birth defects, modern prescribing is tightly controlled. These programs typically require strict pregnancy prevention steps for people who can become pregnant (and for their partners), along with monitoring and counseling to prevent exposure during pregnancy [1].
What should someone do if they took thalidomide during pregnancy?
If thalidomide exposure during pregnancy is suspected or confirmed, the key next step is urgent medical care with an obstetric team and clinicians familiar with teratogen exposure. This often includes reviewing the exact timing and dose, and discussing diagnostic options for evaluating fetal development [1].
Can thalidomide still be used at all?
In some countries, thalidomide is still used for specific conditions under strict controls because it can be effective for certain patients. Use is limited to situations where the benefits outweigh the risks, with strong safeguards to avoid fetal exposure [1].
---
Sources
[1] https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/thalidomide-education-risk-evaluation-and-mitigation-strategy-rems